Wall Street analysts forecast that Waters Co. (NYSE:WAT) will announce earnings of $2.13 per share for the current quarter, according to Zacks Investment Research. Six analysts have provided estimates for Waters’ earnings. The highest EPS estimate is $2.15 and the lowest is $2.11. Waters reported earnings per share of $1.92 during the same quarter last year, which would suggest a positive year over year growth rate of 10.9%. The firm is scheduled to report its next earnings report on Tuesday, October 22nd.

According to Zacks, analysts expect that Waters will report full-year earnings of $9.01 per share for the current year, with EPS estimates ranging from $8.95 to $9.05. For the next financial year, analysts forecast that the firm will post earnings of $10.12 per share, with EPS estimates ranging from $9.82 to $10.82. Zacks’ EPS averages are an average based on a survey of analysts that cover Waters.

Waters (NYSE:WAT) last issued its quarterly earnings data on Tuesday, July 30th. The medical instruments supplier reported $2.14 earnings per share for the quarter, beating analysts’ consensus estimates of $2.11 by $0.03. Waters had a return on equity of 50.64% and a net margin of 24.09%. The company had revenue of $599.20 million for the quarter, compared to the consensus estimate of $601.46 million. During the same quarter last year, the company earned $1.95 earnings per share. The firm’s revenue for the quarter was up .5% compared to the same quarter last year.

A number of analysts have recently weighed in on the stock. Bank of America cut shares of Waters from a “neutral” rating to an “underperform” rating in a report on Tuesday, July 16th. Zacks Investment Research upgraded shares of Waters from a “sell” rating to a “hold” rating and set a $217.00 price objective for the company in a research note on Wednesday, May 22nd. Cleveland Research cut shares of Waters from a “neutral” rating to an “underperform” rating in a research report on Wednesday, June 12th. ValuEngine downgraded shares of Waters from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Finally, Wolfe Research started coverage on shares of Waters in a research note on Thursday, May 30th. They issued an “underperform” rating for the company. Five investment analysts have rated the stock with a sell rating, eight have given a hold rating and one has assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $210.54.

Shares of WAT stock traded up $8.07 during mid-day trading on Wednesday, hitting $231.26. 844,900 shares of the stock traded hands, compared to its average volume of 603,671. The stock has a market cap of $14.49 billion, a P/E ratio of 27.90, a P/E/G ratio of 2.43 and a beta of 1.08. The stock’s fifty day moving average is $211.39 and its two-hundred day moving average is $221.34. Waters has a 52-week low of $167.93 and a 52-week high of $255.21. The company has a debt-to-equity ratio of 2.00, a current ratio of 2.65 and a quick ratio of 2.07.

Hedge funds have recently modified their holdings of the company. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its stake in shares of Waters by 1.2% during the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 4,181 shares of the medical instruments supplier’s stock worth $1,052,000 after buying an additional 49 shares during the period. Cadence Capital Management LLC increased its position in shares of Waters by 1.0% in the 2nd quarter. Cadence Capital Management LLC now owns 5,622 shares of the medical instruments supplier’s stock valued at $1,210,000 after acquiring an additional 53 shares during the period. Piedmont Investment Advisors Inc. raised its stake in Waters by 0.9% in the 1st quarter. Piedmont Investment Advisors Inc. now owns 6,227 shares of the medical instruments supplier’s stock worth $1,567,000 after acquiring an additional 58 shares during the last quarter. GHP Investment Advisors Inc. raised its stake in Waters by 0.8% in the 2nd quarter. GHP Investment Advisors Inc. now owns 8,272 shares of the medical instruments supplier’s stock worth $1,780,000 after acquiring an additional 65 shares during the last quarter. Finally, ETF Managers Group LLC lifted its position in Waters by 10.6% during the 1st quarter. ETF Managers Group LLC now owns 721 shares of the medical instruments supplier’s stock worth $181,000 after acquiring an additional 69 shares during the period. Institutional investors and hedge funds own 95.08% of the company’s stock.

Waters Company Profile

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Recommended Story: Dogs of the Dow

Get a free copy of the Zacks research report on Waters (WAT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.